SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 145 filers reported holding SYNDAX PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,475,651 | -8.0% | 514,852 | +32.6% | 0.02% | 0.0% |
| Q2 2023 | $8,128,207 | +63.5% | 388,352 | +65.0% | 0.02% | +45.5% |
| Q1 2023 | $4,971,014 | -17.0% | 235,370 | 0.0% | 0.01% | -15.4% |
| Q4 2022 | $5,990,167 | +17.9% | 235,370 | +11.4% | 0.01% | 0.0% |
| Q3 2022 | $5,080,000 | +109.2% | 211,368 | +67.5% | 0.01% | +116.7% |
| Q2 2022 | $2,428,000 | +130.1% | 126,191 | +107.8% | 0.01% | +200.0% |
| Q1 2022 | $1,055,000 | -20.7% | 60,737 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $1,330,000 | -65.0% | 60,737 | -69.4% | 0.00% | -62.5% |
| Q3 2021 | $3,796,000 | +294.2% | 198,602 | +253.9% | 0.01% | +300.0% |
| Q2 2021 | $963,000 | -23.2% | 56,118 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $1,254,000 | +37.7% | 56,118 | +36.9% | 0.00% | +50.0% |
| Q4 2020 | $911,000 | +50.8% | 40,977 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $604,000 | +127.1% | 40,977 | +128.2% | 0.00% | +100.0% |
| Q2 2020 | $266,000 | +109.4% | 17,954 | +54.7% | 0.00% | – |
| Q1 2020 | $127,000 | -37.7% | 11,609 | -50.0% | 0.00% | -100.0% |
| Q4 2019 | $204,000 | – | 23,219 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 3,600,000 | $52,272,000 | 8.55% |
| Foresite Capital Management IV, LLC | 875,000 | $12,705,000 | 7.06% |
| Aisling Capital Management LP | 1,025,000 | $14,883,000 | 6.13% |
| Saturn V Capital Management LP | 807,969 | $11,731,710 | 4.91% |
| Eversept Partners, LP | 2,596,245 | $37,697,477 | 3.19% |
| ACUTA CAPITAL PARTNERS, LLC | 297,035 | $4,312,948 | 2.89% |
| Paradigm Biocapital Advisors LP | 2,390,077 | $34,703,918 | 2.36% |
| DAFNA Capital Management LLC | 458,373 | $6,655,576 | 2.07% |
| SPHERA FUNDS MANAGEMENT LTD. | 773,061 | $11,224,846 | 2.04% |
| PFM Health Sciences, LP | 2,715,235 | $39,425,212 | 1.86% |